It was also reported by the subsequent investigations that TMSB4X contributes to tumor aggressiveness through epithelial-mesenchymal-transition (EMT) in pancreatic [25], gastric [26], colorectal [27], lung [28], ovarian [29], and melanoma [30] cancers. This evidence concerns the gene TMSB4X and neoplasm.